Athira Pharma Inc (NASDAQ: ATHA) is -76.88% lower on its value in year-to-date trading and has touched a low of $0.60 and a high of $4.30 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ATHA stock was last observed hovering at around $0.61 in the last trading session, with the day’s loss setting it -0.05%.
Currently trading at $0.56, the stock is -81.22% and -81.45% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.57 million and changing -7.96% at the moment leaves the stock -79.21% off its SMA200. ATHA registered -75.88% loss for a year compared to 6-month loss of -85.59%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -82.16% gain in the last 1 month and extending the period to 3 months gives it a -78.14%, and is -82.92% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.00% over the week and 8.09% over the month.
Athira Pharma Inc (ATHA) has around 67 employees, a market worth around $21.60M and $0.00M in sales. Distance from 52-week low is -6.29% and -86.93% from its 52-week high. The company has generated returns on investments over the last 12 months (-134.50%).
The EPS is expected to grow by 14.02% this year
82.0 institutions hold shares in Athira Pharma Inc (ATHA), with institutional investors hold 65.31% of the company’s shares. The shares outstanding are 38.17M, and float is at 35.54M with Short Float at 2.79%. Institutions hold 63.76% of the Float.
The top institutional shareholder in the company is PERCEPTIVE ADVISORS LLC with over 5.4 million shares valued at $14.32 million. The investor’s holdings represent 14.099 of the ATHA Shares outstanding. As of 2024-06-30, the second largest holder is BAKER BROS. ADVISORS LP with 3.15 million shares valued at $8.36 million to account for 8.2298 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 1.63 million shares representing 4.265 and valued at over $4.33 million, while SIMPLIFY ASSET MANAGEMENT INC. holds 3.8954 of the shares totaling 1.49 million with a market value of $3.96 million.
Athira Pharma Inc (ATHA) Insider Activity
Athira Pharma Inc disclosed in a document filed with the SEC on Sep 05 ’24 that Gengos Andrew (CFO and Chief Business Officer) sold a total of 1,272 shares of the company’s common stock. The trade occurred on Sep 05 ’24 and was made at $0.57 per share for $720.0. Following the transaction, the insider now directly holds 97532.0 shares of the ATHA stock.
Still, SEC filings show that on Sep 05 ’24, Lenington Rachel (COO and CDO) disposed off 2,525 shares at an average price of $0.57 for $1429.0. The insider now directly holds 20,870 shares of Athira Pharma Inc (ATHA).
